The American Bar Association (ABA) Section of Intellectual Property Law, Health Law Section, and Center for Professional Development will be offering a live webinar and teleconference entitled "Mayo v. Prometheus: The Supreme Court's New Methodology for Analyzing Patent Eligibility" on August 21, 2012 from 1:00 - 2:30 pm (EDT). Denise W. DeFranco of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP will moderate a panel including Robert A. Armitage, Senior Vice President and General Counsel for Eli Lilly and Company, and Thomas W. Krauss, Special Counsel for Intellectual Property Litigation for the U.S. Patent & Trademark Office. The panel will cover the U.S. Supreme Court's recent decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc. regarding the eligibility of inventions directed to personalized medicine and more generally to diagnostic methods for treating disease, and explain the Supreme Court's newly articulated methodology for analyzing patent eligibility of inventions implicating laws of nature and how that methodology might be applied to a broad swath of inventions.
The registration fee for the webcast is $95 for members of any of the sections sponsoring the webinar, $99 for government attorneys, $150 for ABA members, and $195 for the general public. Those interested in registering for the webinar, can do so here or by calling 800-285-2221.
Comments